Topics

Latest "The Hillman Company & Hillman Family Foundations" News Stories

03:24 EDT 23rd October 2019 | BioPortfolio

Here are the most relevant search results for "The Hillman Company & Hillman Family Foundations" found in our extensive news archives from over 250 global news sources.

More Information about The Hillman Company & Hillman Family Foundations on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about The Hillman Company & Hillman Family Foundations for you to read. Along with our medical data and news we also list The Hillman Company & Hillman Family Foundations Clinical Trials, which are updated daily. BioPortfolio also has a large database of The Hillman Company & Hillman Family Foundations Companies for you to search.

Showing "Hillman Company Hillman Family Foundations" News Articles 1–25 of 12,000+

Wednesday 23rd October 2019

Sensorion Announces a Poster Presentation of New SENS-401 Preclinical Data at SFN 2019 in Chicago

A poster presentation on the absence of impact due to acoustic trauma on the SENS-401 inner ear exposure in preclinical studies Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biopharmaceutical company which specializes in the development of novel therapies to restore, treat and prevent inner ear diseases such as hearing loss, tinnitus and vertigo,...


Tuesday 22nd October 2019

Hemogenyx Pharmaceuticals PLC Announces Research Agreement with Global Pharma Company

Immugenyx signs a research agreement to develop humanized mice as a tool for drug development and testing LONDON, UK / ACCESSWIRE / October 23, 2019 / Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments designed to transform bone marrow transplantation for the treatment of blood diseases, announces that its wholly owned subsidiary, Immuge...

Evotec, Integra Holdings And Yissum Establish Lab555 To Fast Track Early-Stage Drug Development

FIRST ACADEMIC BRIDGE PARTNERSHIP IN ISRAEL AIMS TO TRANSLATE EARLY-STAGE RESEARCH FROM THE HEBREW UNIVERSITY ("HU") OF JERUSALEM INTO INDUSTRIAL DRUG DEVELOPMENT PROJECTS LAB555 LEVERAGES INTEGRA'S SKILL IN IDENTIFYING AND DEVELOPING PROMISING EARLY-STAGE THERAPEUTIC PROJECTS, YISSUM'S TRANSLATIONAL EXPERTISE AND EVOTEC'S INDUSTRIAL DRUG DEVELOPMENT PLATFORM HAMBURG, GE...


How the malaria parasite jumped from gorillas to humans

Scientists have uncovered the likely series of events that led to the world’s deadliest malaria parasite being able to jump from gorillas to humans, with the results published in the journal PLOS Biology. Plasmodium falciparum is one of seven species of parasite that can cause malaria in a family known as the Laverania. These parasites originated in African great apes and today are restricted t...

Biochemist Aref Kyyaly knew it was time to leave Syria when he was injured in a bombing in Aleppo in 2013. He talks with Nature about leaving Syria with his family and resettling in the UK where he works on allergy research. https://go.nature.com/2Pa79z1

Biochemist Aref Kyyaly knew it was time to leave Syria when he was injured in a bombing in Aleppo in 2013. He talks with Nature about leaving Syria with his family and resettling in the UK where he works on allergy research. https://go.nature.com/2Pa79z1 

Cresco Labs and Origin House Announce Expiration of HSR Waiting Period

Cresco Labs Inc. (“Cresco Labs” or the “Company” – CSE: CL, OTCQX: CRLBF) and CannaRoyalty Corp. d/b/a Origin House (“Origin House” – CSE: OH, OTCQX: ORHOF) are pleased to announce today that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR Act”), has expired with respect to the proposed acquisition of Origin House by Cresco L...

Robert Dempsey Joins iVeena Board of Directors

iVeena Delivery Systems (iVeena), a clinical stage biopharmaceutical company with developmental products in cataract and cornea, announces the appointment of Robert Dempsey, former Group Vic

#Cdifficile bacteria can be found anywhere in the environment . Watch as Dr. Nicholas Kitchin talks with a patient advocate about her family’s experience with #Cdifficile infection & the potential future of prevention: https://on.pfizer.com/31Dhc2j pi

#Cdifficile bacteria can be found anywhere in the environment . Watch as Dr. Nicholas Kitchin talks with a patient advocate about her family’s experience with

Eviana Health Corporation: Eviana Announces Resignation of Director

TORONTO, ON / ACCESSWIRE / October 22, 2019 / Eviana Health Corporation (CSE:EHC) (the "Company") announces that effective October 21, 2019, Paolo De Luca has resigned as a director of the Company....

Quanterix to Release Third Quarter 2019 Financial Results and Host Conference Call on November 6, 2019

Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that it will release its financial results for third quarter 2019 after the close of trading on Wednesday, November 6, 2019. Company management will host a conference call at 4:30 p.m., ET to discuss Quanterix’ financial results and provide a b...

Healthcare Services Group, Inc. Reports Q3 Results, Cash Dividend Increase

Healthcare Services Group, Inc. (NASDAQ:HCSG) (the “Company”) reported for the three months ended September 30, 2019 revenue of $455 million, net income of $18.3 million or $0.25 per basic and diluted common share and cash flow from operations of $60 million. The Company declared a quarterly cash dividend of $0.20 per share, its 66th consecutive quarterly cash dividend. Third Quarter Result...

Dementia patients’ adult kids develop symptoms six years earlier than their parents

A person's chance of developing dementia is influenced by family history, variations in certain genes, and medical conditions such as cardiovascular disease and diabetes. But less is known about the factors that affect when the first symptoms of forgetfulness and confusion will arise.

USANA Health Sciences Reports Third Quarter 2019 Results

Third quarter net sales of $260.6 million Third quarter net earnings of $24.2 million, or $1.09 per diluted share Company narrows 2019 Net Sales and EPS outlook on updated FX outlook for the year USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal third quarter ended September 28, 2019. Financial Performance Third quarter 2019 net sales were $260.6...

Transcat Reports Consolidated Operating Income Growth of 40% and Service Segment Revenue Growth of 18% for Fiscal 2020 Second Quarter

Service segment revenue increased 18.1% with strong Service organic growth of 15.1% Productivity initiatives developing early traction as Service segment gross margin expanded 140 basis points; consolidated gross profit margin increased 150 basis points Consolidated operating income grew more than 40% on total revenue growth of 7.4% Achieved net income of $2.4 million and diluted earnings...

Moderna Receives FDA Fast Track Designation for Propionic Acidemia Program (mRNA-3927)

mRNA-3927 is Moderna’s second rare disease program to receive Fast Track designation mRNA-3927 uses the same proprietary LNP formulation as mRNA-1944 (antibody against Chikungunya virus) and mRNA-3704 (methylmalonic acidemia) Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformat...

Longtime Texas Health Care Execs Launch Devoted Health, a next-generation Medicare Advantage plan, in Houston metro area

Nationally-recognized MA plan enrolling seniors in Harris, Waller, Montgomery, and Fort Bend counties Devoted Health, a next-generation Medicare Advantage plan dedicated to delivering the highest-quality, hassle-free health care to Medicare beneficiaries, announced that it is enrolling members into two new plans across four counties in the Houston metro area. Leading the efforts in Houston are...

Inogen to Announce Third Quarter 2019 Financial Results on Tuesday, November 5, 2019

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release third quarter 2019 financial results after market close on Tuesday, November 5, 2019. The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET. Individuals interested in listening to the conference call m...

Fitbit Schedules Q319 Financial Results for November 6, 2019

Fitbit (NYSE: FIT), the leading global wearables brand, today announced that it expects to release results for its third quarter 2019 on Wednesday, November 6, after market close. In conjunction with a press release, management will host a conference call at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time that afternoon. A live webcast of the conference call will be available on the Investor sect...

Jamieson Wellness Inc. Announces Date of Third Quarter 2019 Financial Results and Conference Call

Jamieson Wellness Inc. ("Jamieson Wellness" or the "Company") (TSX:JWEL) announced today that the Company will release its third quarter 2019 financial results after the market close on Wednesday, November 6, 2019. The Company will host a conference call for investors at 5:00 p.m. Eastern Time to discuss the third quarter 2019 results. The call can be accessed live over the telephone by dialing...

Cutera, Inc. to Announce Third Quarter 2019 Results

Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of laser and energy-based aesthetic systems for practitioners worldwide, will announce financial results for the third quarter 2019 on Thursday, November 7, 2019 after market close. The Company will also host a conference call to discuss these results with additional comments and details. Participating on the call...

AngioDynamics Announces Departure of CFO and Appointment of Interim CFO

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Michael C. Greiner, Executive Vice President and Chief Financial Officer (CFO) will be departing the Company. Stephen A. Trowbridge, Senior Vice President and General Counsel, will assume the role of interim C...

CanadaBis Capital Inc. Acquires $3.5 Million In Bank Financing and Extends the Terms of Existing Warrants

RED DEER, AB / ACCESSWIRE / October 22, 2019 / CanadaBis Capital Inc. ("CanadaBis" or "the Company"), through its subsidiary 1998643 Alberta Ltd. ("Stigma Grow"), is pleased to announce that it has successfully executed its option to purchase its leased cultivation facility, located in Red Deer County, Alberta. The operating facility currently holds a Health Canada-i...

Irving Company Announces Alabama Alliance: USOSM Forms Partnership with Clark Holmes Oral Facial Surgery

U.S. Oral Surgery Management (USOSM) – a specialty management services company headquartered in Irving, Texas – has formed a new partnership with Clark Holmes Oral Facial Surgery of Alabama, an oral and maxillofacial surgery practice with four Alabama locations. It is USOSM’s first partnership in the state. IRVING, Texas (PRWEB) October 22, 2019 U.S. Oral Surgery Management (USOSM) – a sp...

Zuellig Pharma enters into strategic partnership with Eli Lilly and Company in Malaysia and Thailand

SINGAPORE, Oct. 22, 2019 /PRNewswire/ -- Zuellig Pharma, a leading healthcare service provider in Asia, is pleased to announce two new strategic partnerships with Eli Lilly and Company (Lilly) to market, sell and distribute the healthcare manufacturer's existing and new products in Malaysia and

Eviana Announces Resignation of Director

TORONTO, ON / ACCESSWIRE / October 22, 2019 / Eviana Health Corporation (CSE:EHC) (the "Company") announces that effective October 21, 2019, Paolo De Luca has resigned as a director of the Company. Management and the board of directors would like to thank Mr. De Luca for his contributions to the Company. About Eviana Health Corporation The Company was established with the aim of deliv...


Quick Search

News Quicklinks